卖什么
从转诊到交付的医疗器械供应链。
商业模式拆解
买家：谁掌握预算？
Owners and clinical leads at orthotics and prosthetics (O&P), DME and podiatry practices.
触发点：什么让他们现在购买？
Medicare documentation burden, slow outside-lab fabrication and thin margins; patients wait weeks for devices.
工作流：什么输入变成什么输出？
Referral fax auto-processed and matched, payer eligibility check, compliance documentation assembled, clinical evaluation and SOAP note (about 10 minutes), unified ordering portal, in-house 3D-printed fabrication and shipping in days.
经济账：省了什么，怎么收费？
Software plus in-house lab producing custom devices; testimonial cites turnaround cut from 5-6 weeks to 2 weeks; claims remake rate under 20%.
渠道：怎么接触到客户？
Demo-led sales ("Book a demo").
融资历史与报道
| 融资日期 | 轮次 | 金额 | 投资方 | 来源 |
|---|---|---|---|---|
| 2026-08-25 | — | $22.5M | — | news.google.com |
档案汇总自公开报道和公司官网。商业模式部分是 MaxBC 对这些材料的解读，不是已确认的事实；未知之处留空，不作猜测。 更新于 2026-10-12.